FDAnews
www.fdanews.com/articles/62950-acambis-sells-berna-products-to-crucell-for-16-5m

ACAMBIS SELLS BERNA PRODUCTS TO CRUCELL FOR $16.5M

October 2, 2006

Acambis plc ("Acambis") announces the sale of its Berna Products Corporation ("Berna Products") business to Crucell NV ("Crucell"). Berna Products is no longer a strategic asset for Acambis following the termination of the ARILVAX licensing agreement, which was announced on 12 September. The sale agreement and consequential termination of the product distribution agreement between Berna Products and Crucell resulted in Acambis receiving cash proceeds of $16.5m (c.£9m). Market Wire (http://www.marketwire.com/mw/release_html_b1?release_id=168290)